V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270017058 | 270010409 | 1.79 | null | Adjuvant (A) | 2018-02-24 | 2018-04-23 | DHAP - R | N | null | 270021079 | CYCLOPHOSPHAMIDE + DACARBAZINE + VINCRISTINE |
| 270017059 | 270014863 | 1.59 | 57.2 | Disease modification (D) | 2017-11-13 | 2017-11-27 | ETOPOSIDE | N | N | 270021099 | CHLORAMBUCIL |
| 270017060 | 270010413 | 1.9 | null | Palliative (P) | 2017-10-22 | 2017-10-22 | RATHL TRIAL | N | N | 270021126 | ICE |
| 270017061 | 270010416 | 1.64 | 80.3 | Neo-adjuvant (N) | 2018-01-07 | 2018-01-12 | CVP R | 02 | N | 270021161 | NHL 2003 |
| 270017062 | 270017200 | null | 86.6 | Palliative (P) | 2014-02-08 | 2015-04-18 | BREVITY TRIAL | N | N | 270021184 | METHOTREXATE HIGH DOSE |
| 270017063 | 270010418 | 1.81 | 70.9 | Adjuvant (A) | 2016-11-16 | 2017-07-22 | Hydroxycarbamide | N | N | 270021203 | LENALIDOMIDE |
| 270017064 | 270010420 | 1.56 | 54.25 | Palliative (P) | 2016-03-15 | 2016-03-18 | ICE | N | N | 270021238 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270017065 | 270010424 | 1.75 | 101.8 | Curative (C) | 2015-11-06 | 2016-01-23 | CARBOPLATIN + CETUXIMAB + FU | N | N | 270021351 | CVP R |
| 270017066 | 270010427 | 1.9 | 77.3 | Not known (9) | 2011-10-05 | 2015-03-16 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | 2 | N | 270021359 | DACARBAZINE |
| 270017067 | 270014869 | 1.75 | null | Palliative (P) | 2016-11-30 | 2018-07-17 | BLEOMYCIN | N | N | 270021362 | RATHL TRIAL |
| 270017068 | 270010428 | null | null | Disease modification (D) | 2017-09-21 | 2017-09-22 | RATHL TRIAL | N | null | 270021484 | CHLVPP/PABLOE |
| 270017069 | 270010429 | null | 76 | Palliative (P) | 2015-06-04 | 2015-06-10 | BENDAMUSTINE + Brentuximab Vendotin | N | null | 270021486 | CARBO + FLUOROURACIL |
| 270017070 | 270014872 | 0 | 52.4 | Palliative (P) | 2017-09-10 | 2017-09-10 | CHLVPP PABLOE | N | N | 270021504 | RATHL TRIAL |
| 270017071 | 270010433 | null | 91 | Palliative (P) | 2019-01-25 | 2019-01-25 | CHLVPP/EVA | N | N | 270021516 | ICE-R |
| 270017072 | 270010435 | null | 76 | Adjuvant (A) | 2017-06-05 | 2017-06-17 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 270021527 | VINCRISTINE |
| 270017073 | 270017205 | 1.78 | 65 | Palliative (P) | 2017-10-09 | 2017-12-06 | BREVITY TRIAL | 02 | N | 270021549 | FLUDARABINE + MELPHALAN |
| 270017074 | 270010436 | 1.75 | null | Disease modification (D) | 2018-05-09 | 2018-08-05 | DOXORUBICIN | N | null | 270021605 | RUXOLITINIB |
| 270017075 | 270010437 | 1.61 | 82.8 | Palliative (P) | 2016-11-15 | 2016-11-19 | R GDP | 02 | N | 270021606 | BLEOMYCIN |
| 270017076 | 270014876 | 1.57 | 89 | Curative (C) | 2016-10-08 | 2016-10-14 | Temozolomide 150mg/m2 | N | Y | 270021620 | ECHELON 1 TRIAL |
| 270017077 | 270010439 | 1.63 | 57 | Curative (C) | 2018-01-31 | 2018-02-14 | BLEOMYCIN | 2 | N | 270021638 | CHLVPP/PABLOE |
| 270017078 | 270010441 | 1.81 | 83 | Palliative (P) | 2016-05-20 | 2016-06-16 | IBRUTINIB | N | N | 270021686 | CHLVPP/PABLOE |
| 270017079 | 270010441 | null | 83.7 | Palliative (P) | 2018-04-05 | 2018-04-30 | RATHL TRIAL | 2 | N | 270021686 | PACLITAXEL |
| 270017080 | 270010443 | 1.6 | 81 | Palliative (P) | 2014-09-27 | 2014-09-27 | Methotrexate intrathecal | 2 | N | 270021799 | FLUDARABINE + MELPHALAN |
| 270017081 | 270019291 | 1.72 | 45 | Adjuvant (A) | 2016-12-24 | 2017-02-17 | Bortezomib + Panobinostat | 02 | N | 270021829 | ECHELON 1 TRIAL |
| 270017082 | 270010445 | 1.93 | 60 | Adjuvant (A) | null | 2016-09-16 | CHOEP - 21 days | N | N | 270021842 | ICE |
| 270017083 | 270010450 | 1.79 | 78 | null | 2017-08-04 | 2017-08-11 | ETOPOSIDE | N | null | 270021910 | CVP R |
| 270017084 | 270010452 | 1.69 | 83.4 | null | 2018-05-11 | 2018-05-23 | CHLVPP PABLOE | 02 | N | 270021968 | METHOTREXATE INTRATHECAL |
| 270017085 | 270010454 | 1.68 | 83.7 | Neo-adjuvant (N) | 2017-01-25 | 2017-03-07 | VINCRISTINE | N | Y | 270022047 | BENDAMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN |
| 270017086 | 270010455 | 1.65 | 70.5 | null | 2017-05-01 | 2017-05-16 | CAPECITABINE + CETUXIMAB + IRINOTECAN | N | N | 270022064 | BEVACIZUMAB + CAPE + IRINOTECAN |
| 270017087 | 270010456 | null | 64.1 | Not known (9) | 2017-04-30 | 2017-05-08 | BOSUTINIB | N | null | 270022072 | CLADRIBINE |
| 270017088 | 270014889 | 1.78 | 78.3 | Not known (9) | 2017-10-02 | 2017-10-02 | DTPACE | 02 | N | 270022133 | CYCLOPHOSPHAMIDE |
| 270017089 | 270010462 | 1.63 | null | Disease modification (D) | 2015-12-27 | 2016-03-06 | Cisplatin + Etoposide (3 day) | N | N | 270022153 | RUXOLITINIB |
| 270017090 | 270010463 | 1.65 | 128 | null | 2014-10-14 | 2014-10-15 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE | 02 | N | 270022158 | CHLVPP/PABLOE |
| 270017091 | 270010465 | -1 | 67.4 | Curative (C) | 2016-12-26 | 2017-09-05 | Methotrexate 25-50mg/m2 iv 7day | 02 | N | 270022215 | CISPLATIN + ETOPOSIDE |
| 270017092 | 270010469 | 1.82 | 105.4 | Palliative (P) | 2016-12-28 | 2016-12-28 | Bevacizumab+Carbo+Gemcitabine | N | N | 270022244 | CVP R |
| 270017093 | 270010470 | 1.71 | 53.9 | Palliative (P) | 2015-12-14 | 2015-12-20 | VAPEC-B | N | N | 270022247 | CARMUSTINE + CYTARABINE + ETOPOSIDE |
| 270017094 | 270010473 | 1.72 | null | Curative (C) | 2014-10-26 | 2014-11-03 | BLEOMYCIN | N | null | 270022281 | FLUDARABINE + MELPHALAN |
| 270017095 | 270010474 | 1.78 | 100 | Curative (C) | 2014-04-04 | 2014-05-14 | IMATINIB | null | null | 270022283 | BENDAMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN |
| 270017096 | 270010477 | 1.7 | 58 | null | null | 2016-02-16 | PMitCEBOM | N | N | 270022307 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 270017097 | 270010480 | 1.76 | 92 | Curative (C) | 2016-07-13 | 2016-10-14 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 270022325 | BREVITY TRIAL |
| 270017098 | 270010481 | 1.83 | 92.6 | Curative (C) | 2016-07-18 | 2016-08-21 | ETOPOSIDE | N | N | 270022352 | ICE-R |
| 270017099 | 270010485 | null | 64.3 | Palliative (P) | 2018-07-15 | 2018-07-15 | BENDAMUSTINE + RITUXIMAB | N | N | 270022424 | PROCARBAZINE |
| 270017100 | 270010489 | 1.8 | 53.8 | Curative (C) | 2014-12-02 | 2014-12-23 | ICE-R | null | N | 270022471 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 270017101 | 270010489 | 1.74 | null | Palliative (P) | 2018-04-06 | 2018-05-19 | Bortezomib +/- Dexamethasone | N | N | 270022471 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270017102 | 270010490 | null | 58.8 | Curative (C) | 2014-11-21 | 2015-07-25 | ECHELON 1 TRIAL | N | N | 270022530 | ICE |
| 270017103 | 270010492 | 1.79 | 86.55 | Palliative (P) | 2014-10-23 | 2014-11-20 | FEC 100 | N | N | 270022540 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270017104 | 270010495 | null | 102.8 | Curative (C) | 2015-07-21 | 2015-08-12 | Alemtuz+Cyclophos+Fludara Allo | N | N | 270022551 | RATHL TRIAL |
| 270017105 | 270010497 | 1.8 | 104.3 | Adjuvant (A) | 2016-09-12 | 2016-09-30 | DOXORUBICIN | N | N | 270022568 | BENDAMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN |
| 270017106 | 270010499 | 1.8 | 74 | Curative (C) | 2013-11-07 | 2013-12-05 | R GCVP | 2 | N | 270022619 | METHOTREXATE INTRATHECAL |
| 270017107 | 270010501 | 1.76 | 66.5 | Curative (C) | 2017-09-28 | 2017-09-28 | ICE + GCSF | N | N | 270022634 | CARBOPLATIN + RT |